Skip to main content

Table 2 Characteristics of women who intend to use antidepressant medication in pregnancy (n = 46) and those who do not intend to use antidepressant medication in pregnancy (n = 49). Categorical variables presented as n (%) and compared using chi-squared (x2) tests, and continuous variables presented as mean ± standard deviation (SD) and compared using independent t-tests

From: Decision-making about antidepressant medication use in pregnancy: a comparison between women making the decision in the preconception period versus in pregnancy

Variable

Intends to use antidepressant in pregnancy

(n = 46)

Intends to not use antidepressant in pregnancy

(n = 49)

Test statistic; P-value

Demographics and Health History

 Age in years, Mean ± SD

33.6 ± 4.3

33.6 ± 4.2

t = 0.02; p = 0.99

 Married or cohabitating with partner, n (%)

45 (97.8)

42 (85.7)

x2 = 4.51; p = 0.03

 Completed a university degree, n (%)

43 (93.5)

48 (98.0)

x2 = 1.18; p = 0.28

 Annual household income (CAD/year), n (%)

  

x2 = 6.19; p = 0.18

   < 40,000

1 (2.2)

6 (12.3)

 

  40,000-80,000

12 (26.1)

17 (34.7)

 

   > 80,000

32 (69.6)

26 (53.1)

 

  Preferred not to answer

1 (2.2)

0 (0.0)

 

 Canadian-born, n (%)

40 (87.0)

42 (85.7)

x2 = 1.29; p = 0.52

 Nulliparous, n (%)

29 (63.0)

31 (63.3)

x2 = 0.001; p = 0.98

 Current smoker, n (%)

3 (6.5)

4 (8.2)

x2 = 0.09; p = 0.76

 Other medical condition, n (%)

12 (26.7)

22 (44.9)

x2 = 3.38; p = 0.07

Psychiatric History

 Lifetime antidepressant use, n (%)

44 (95.7)

47 (97.9)

x2 = 0. 39; p = 0.53

 Prior response to antidepressants, n (%)a

  

x2 = 4.46; p = 0.11

  No effect

1 (2.2)

5 (10.9)

 

  Moderate effect

10 (21.7)

15 (32.6)

 

  Beneficial effect

33 (71.7)

26 (56.5)

 

 Prior adverse effects from antidepressants, n(%)a

18 (40.9)

19 (41.3)

x2 = 0.001; p = 0.97

 Lifetime psychiatric hospitalization, n (%)

5 (10.9)

4 (8.2)

x2 = 0.20; p = 0.65

Current mental health treatmentb

 Antidepressant medication, n (%)

42 (91.3)

23 (46.9)

x2 = 21.6; p < .001

 Individual therapy, n (%)

15 (32.6)

22 (44.9)

x2 = 1.51; p = 0.22

 Group therapy, n (%)

2 (4.3)

1 (2.0)

x2 = 0.41; p = 0.52

 Psychiatrist, n (%)

16 (34.8)

21 (42.9)

x2 = 0.65; p = 0.42

 Family doctor, n (%)

29 (63.0)

18 (36.7)

x2 = 10.2; p < 0.01

 Social worker, n (%)

1 (2.2)

6 (12.2)

x2 = 3.38; p = 0.07

 Psychologist, n (%)

6 (13.0)

9 (18.4)

x2 = 0.41; p = 0.52

Scales

 Edinburgh Postnatal Depression Scale, Mean ± SD

11.1 ± 5.6

13.4 ± 4.3

t = −2.28; p = 0.02

 High Edinburgh Postnatal Depression Scale (≥13), n(%)

20 (43.5)

28 (57.1)

x2 = 1.77; p = 0.18

 State-Trait Anxiety Inventory (Trait), Mean ± SD

48.4 ± 12.0

50.5 ± 9.2

t = −0.95; p = 0.34

 High State-Trait Anxiety Inventory (Trait) (≥40), n(%)

35 (76.1)

42 (85.7)

x2 = 1.43; p = 0.23

 State-Trait Anxiety Inventory (State), Mean ± SD

41.9 ± 13.2

45.9 ± 12.8

t = −1.47; p = 0.15

 High State-Trait Anxiety Inventory (State) (≥40), n(%)

18 (39.1)

30 (61.2)

x2 = 4.63; p = 0.03

 Decisional Conflict Scale, Mean ± SD

43.7 ± 15.6

49.0 ± 13.6

t = − 1.74; p = 0.08

 High Decisional Conflict Scale (≥37.5), n (%)

29 (63.0)

41 (83.7)

x2 = 5.21; p = 0.02

 Knowledge Score, Mean ± SD

64.8 ± 8.4

64.6 ± 9.8

t = 0.43; p = 0.67

  1. aPercentage of those who had used antidepressive agents. Note that prior benefit/side effects is missing for one participant who did not intend to take antidepressants
  2. bThese categories are not mutually exclusive